LinkedIn Profile

Access Intensity Therapeutics historical Linkedin company profile data on number of followers, employee headcount and more

Records

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Ticker Sector Ticker Industry
private:intensitytherapeutics 3220740 Jun 19th, 2019 12:00AM Intensity Therapeutics, Inc. 201 9.00 Open Pharmaceuticals Jun 19th, 2019 11:33AM Jun 19th, 2019 11:33AM Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases. Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc. Open Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine Open 61 Wilton Road, 3rd Floor Westport CT US 06880 Health Care Equipment & Services
private:intensitytherapeutics 3220740 Jun 18th, 2019 12:00AM Intensity Therapeutics, Inc. 201 9.00 Open Pharmaceuticals Jun 17th, 2019 11:36PM Jun 17th, 2019 11:36PM Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases. Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc. Open Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine Open 61 Wilton Road, 3rd Floor Westport CT US 06880 Health Care Equipment & Services
private:intensitytherapeutics 3220740 Jun 17th, 2019 12:00AM Intensity Therapeutics, Inc. 201 9.00 Open Pharmaceuticals Jun 17th, 2019 12:44PM Jun 17th, 2019 12:44PM Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases. Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc. Open Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine Open 61 Wilton Road, 3rd Floor Westport CT US 06880 Health Care Equipment & Services
private:intensitytherapeutics 3220740 Jun 16th, 2019 12:00AM Intensity Therapeutics, Inc. 201 9.00 Open Pharmaceuticals Jun 16th, 2019 06:04PM Jun 16th, 2019 06:04PM Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases. Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc. Open Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine Open 61 Wilton Road, 3rd Floor Westport CT US 06880 Health Care Equipment & Services
private:intensitytherapeutics 3220740 Jun 15th, 2019 12:00AM Intensity Therapeutics, Inc. 201 9.00 Open Pharmaceuticals Jun 15th, 2019 02:14PM Jun 15th, 2019 02:14PM Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases. Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc. Open Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine Open 61 Wilton Road, 3rd Floor Westport CT US 06880 Health Care Equipment & Services
private:intensitytherapeutics 3220740 Jun 14th, 2019 12:00AM Intensity Therapeutics, Inc. 201 9.00 Open Pharmaceuticals Jun 14th, 2019 12:16PM Jun 14th, 2019 12:16PM Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases. Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc. Open Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine Open 61 Wilton Road, 3rd Floor Westport CT US 06880 Health Care Equipment & Services
private:intensitytherapeutics 3220740 Jun 13th, 2019 12:00AM Intensity Therapeutics, Inc. 199 8.00 Open Pharmaceuticals Jun 13th, 2019 12:25PM Jun 13th, 2019 12:25PM Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases. Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc. Open Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine Open 61 Wilton Road, 3rd Floor Westport CT US 06880 Health Care Equipment & Services
private:intensitytherapeutics 3220740 Jun 12th, 2019 12:00AM Intensity Therapeutics, Inc. 198 8.00 Open Pharmaceuticals Jun 12th, 2019 11:35AM Jun 12th, 2019 11:35AM Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases. Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc. Open Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine Open 61 Wilton Road, 3rd Floor Westport CT US 06880 Health Care Equipment & Services
private:intensitytherapeutics 3220740 Jun 11th, 2019 12:00AM Intensity Therapeutics, Inc. 198 8.00 Open Pharmaceuticals Jun 11th, 2019 02:35PM Jun 11th, 2019 02:35PM Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases. Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc. Open Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine Open 61 Wilton Road, 3rd Floor Westport CT US 06880 Health Care Equipment & Services
private:intensitytherapeutics 3220740 Jun 10th, 2019 12:00AM Intensity Therapeutics, Inc. 198 8.00 Open Pharmaceuticals Jun 10th, 2019 10:35AM Jun 10th, 2019 10:35AM Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases. Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc. Open Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine Open 61 Wilton Road, 3rd Floor Westport CT US 06880 Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.